Bay City Capital is a leading investment firm that provides capital to innovative companies in the biotechnology and pharmaceutical industries through its business segments including portfolio company financing, joint venture investments, M&A activity, strategic partnerships, and research collaborations. With a presence in San Francisco and a diverse range of portfolio companies across various therapeutic areas, Bay City Capital supports the development and growth of groundbreaking treatments for patients with serious diseases.